OPKO Health
OPK
#5825
Rank
โ‚ฌ1.14 B
Marketcap
1,54ย โ‚ฌ
Share price
0.00%
Change (1 day)
34.20%
Change (1 year)

EPS for OPKO Health (OPK)

EPS in 2026 (TTM): -0,17ย โ‚ฌ

According to OPKO Health 's latest financial reports the company's current EPS (TTM) is -0,17ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -0,27ย โ‚ฌ a decrease over its 2024 EPS that were of -0,06306ย โ‚ฌ.

EPS history for OPKO Health from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-0,17ย โ‚ฌ-38.91%
2025-0,27ย โ‚ฌ328.57%
2024-0,06306ย โ‚ฌ-72%
2023-0,23ย โ‚ฌ-43.18%
2022-0,40ย โ‚ฌ780%
2021-0,04504ย โ‚ฌ-200%
20200,04504ย โ‚ฌ-109.43%
2019-0,48ย โ‚ฌ96.3%
2018-0,24ย โ‚ฌ-49.06%
2017-0,48ย โ‚ฌ1225%
2016-0,03603ย โ‚ฌ-54.06%
2015-0,07843ย โ‚ฌ-78.23%
2014-0,36ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
6,02ย โ‚ฌ-3,615.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
2,44ย โ‚ฌ-1,523.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
42,32ย โ‚ฌ-24,826.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
4,07ย โ‚ฌ-2,478.95%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
11,05ย โ‚ฌ-6,557.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
17,84ย โ‚ฌ-10,526.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
0,41ย โ‚ฌ-336.84%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Ardelyx
ARDX
-0,20ย โ‚ฌ 15.79%๐Ÿ‡บ๐Ÿ‡ธ USA